This article is more than 5 years old. Information may no longer be current.
Berman named IlluminOss VP of Clinical Affairs
Click Here to Manage Email Alerts
IlluminOss Medical recently announced Amy Orlick Berman as the company’s new vice president of clinical affairs.
Joining the company from Cordis, Johnson & Johnson, Berman brings nearly 20 years of experience in the field into her new role. As part of her responsibilities as vice president of clinical affairs, she will oversee the company’s global clinical trial program, according to a company press release.
“Ms. Berman has an impressive track record of fostering successful partnerships with the FDA, clinical research organizations, vendors and international scientific advisors to ensure approval and release of new medical devices and drug therapies,” Robert Rabiner, president and CEO of IlluminOss Medical, said in the release. “We are pleased to make her a part of the IlluminOss Medical team and are confident she is the right fit to support the clinical trial efforts for the IlluminOss System.”
“It’s a pivotal time for IlluminOss Medical, and I am excited to be a part of the effort to validate its groundbreaking technology, which is expected to revolutionize fracture repair by providing a much less invasive option that can benefit both the orthopedic surgeon and their patient,” Berman said in the release.
Reference: www.illuminoss.com.